Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $5.1900 (5.92%) ($5.1900 - $5.1900) on Sun. May. 29, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.35% (three month average) | RSI | 42 | Latest Price | $5.1900(5.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -4.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting ATRA price | ATRA will decline at least -2.675% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.675% (StdDev 5.35%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-22.71(-537.57%) | Resistance Level | $5.6 | 5 Day Moving Average | $4.92(5.49%) | 10 Day Moving Average | $5.08(2.17%) | 20 Day Moving Average | $5.6(-7.32%) | To recent high | -48.9% | To recent low | 10.7% | Market Cap | $N/A | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |